LIH Newsletter | #10
In our 10th edition we're thrilled to share that LIH's Cancer Metabolism Group has been awarded a historic grant of €?? ?????????????? from the European Research Council (ERC) . ? Elsewhere, learn about recent key discoveries and fantastic achievements from our LIH colleagues.
Enjoy the read.
LATEST NEWS
Prestigious grant empowers pursuit against metastatic cancer
In a significant stride against cancer, LIH's Cancer Metabolism Group, led by Johannes Meiser has secured €2 million from the European Research Council (ERC) . This grant, considered the pinnacle of scientific achievement in Europe, is a first in LIH's history, underscoring the institute's commitment to pioneering research.
Read more: https://www.lih.lu/en/article/prestigious-grant-empowers-pursuit-against-metastatic-cancer/
LIH scientist takes the lead in global cancer epidemiology
Congratulations to Dr Claudine Backes epidemiologist and Scientific Director of the Luxembourg National Cancer Registry, who was recently elected as the new President of the GRELL, one of the oldest cancer research associations worldwide. Her new role will provide vital in advancements in the field of cancer research, improving prevention, enhancing treatment, and supporting healthcare planning.
Read more: https://www.lih.lu/en/article/lih-scientist-takes-the-lead-in-global-cancer-epidemiology/
Luxembourg discovery advances Parkinson’s disease diagnosis
In a ground-breaking study, scientists from LIH's Allergy and Clinical Immunology Research Team, in collaboration with the Luxembourg Centre for Systems Biomedicine (LCSB) - University of Luxembourg have unlocked a crucial key to early Parkinson’s disease diagnosis. Their research introduces non-invasive cellular immune biomarkers that could redefine how we identify and address this complex neurodegenerative disease in the near future.
Read more: https://www.lih.lu/en/article/luxembourg-discovery-advances-parkinsons-disease-diagnosis/
FNR 2023 CORE Call preliminary results - 4 LIH projects selected for funding
In November, the Luxembourg National Research Fund (FNR) announced the preliminary results of its 2023 CORE Call. A total of 38 out of the 188 eligible proposals were retained for funding, corresponding to an FNR financial commitment of EUR 26.02 million. Among these are 4 projects involving the LIH across our priority disease areas, for a total financial support amounting to over €2.5 million.
INTERVIEW | Diabetes: A multi-faceted approach to a multi-faceted disease
Hear from LIH's Deep Digital Phenotyping Research Unit group leader Dr Guy Fagherazzi who takes us through the research projects that are actively improving the screening, and care of this complex disease, addressing it from various angles.
Read more: https://www.lih.lu/en/article/diabetes-a-multi-faceted-approach-to-a-multi-faceted-disease/
Minister for Higher Education and Research visits the LCTR
Last week we were delighted to welcome the newly elected Minister for Higher Education and Research, Stéphanie Obertin for a visit of our LCTR building.The guided tour of the facilities featured a series of presentations focusing on LIH's current and future activities across different departments, led by CEO Ulf Nehrbass and President of the Board of Directors, Gregor Baertz.
LIH to lead European Project on Treatment Resistance in Deadly Brain Tumours
Recognising the urgent need to understand the resistance mechanisms underlying glioblastoma (GBM), the EU-driven Horizon 2020 TRANSCAN-3 programme has decided to fund a multinational project coordinated by the NORLUX Neuro-Oncology Laboratory at the LIH. The project, known as PLASTIG aims to unravel the complex and elusive mechanisms that enable GBM to resist treatment.
LIH shapes the future of translational allergy research
Congratulations to LIH's Molecular and Translational Allergology Group who have been recognised internationally with 2 papers featured in the prestigious Allergy EAACI journal. As part of this, a groundbreaking study by Dr. Annette Kuehn to identify biomarkers in peanut allergies and work by Dr. Christiane Hilger alongside a number of international experts addressing information needs in allergy diagnosis and treatment featured in the publication.
Hair as a “witness” to exposure to fast-elimination chemicals
Hair analysis can be a good way of monitoring exposure to chemicals that are rapidly eliminated from the body. This has been demonstrated by a study conducted by the LIH, Agence nationale de sécurité sanitaire - Anses & Ineris - Institut national de l'environnement industriel et des risques . This work has specified for which molecules this analysis is most relevant.
Read more: https://www.lih.lu/en/article/hair-as-a-witness-to-exposure-to-fast-elimination-chemicals/
Head of Tumor Immunotherapy and Microenvironment (TIME) Research Group - Luxembourg Institute of Health - Executive Editor Journal of Cellular Biochemistry
11 个月Outstanding achievement, well done